Summit Therapeutics Inc. Liabilities
Summit Therapeutics Inc. (SMMT) had Liabilities of GBP 17.26 million as of 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Notes
ifrs-full:Liabilities · last filed 2020-06-02
- 2020-03-31: Liabilities 17.26M GBP.
- 2019-12-31: Liabilities 13.90M GBP.
- 2019-10-31: Liabilities 12.49M GBP.
- 2019-07-31: Liabilities 14.72M GBP.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2020-03-31 | 17.26M GBP 6-K · filed 2020-06-02 | |
| 2019-12-31 | 13.90M GBP 6-K · filed 2020-06-02 | |
| 2019-10-31 | 12.49M GBP 6-K · filed 2019-12-17 | |
| 2019-07-31 | 14.72M GBP 6-K · filed 2019-10-11 | |
| 2019-04-30 | 15.01M GBP 6-K · filed 2019-06-12 | |
| 2019-01-31 | 18.10M GBP 20-F · filed 2020-04-30 | 17.23M GBP 20-F · filed 2019-03-29 |
| 2018-10-31 | 16.79M GBP 6-K · filed 2018-12-11 | |
| 2018-07-31 | 13.72M GBP 6-K · filed 2018-09-20 | |
| 2018-04-30 | 57.97M GBP 6-K · filed 2018-06-05 | |
| 2018-01-31 | 58.33M GBP 20-F · filed 2020-04-30 | 44.09M GBP 20-F · filed 2018-04-13 |
| 2017-01-31 | 41.08M GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |